Carcinoma gastric

Botterweck, A. A. et al., Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma results from a prospective study after 6.3 years of foUow-up, Cancer, 88, 131, 2000. [Pg.142]

Helicobacter pylori is associated with chronic gastritis, peptic ulceration and possibly involved in the pathogenesis of gastric carcinoma (Correa and Ruiz, 1992 Dixon,... [Pg.144]

Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002 62 2937-2941. [Pg.347]

Memik, F., Nak, S. G., Gulten, M., Ozturk, M., Gastric carcinoma in Northwestern Turkey Epidemiologic characteristics, J Environ Pathol Oncol, 11, 335, 1992. [Pg.345]

Rojo F, Tabernero J, Albanell J, et al. Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma. J. Clin. Oncol. 2006 24 4309-4316. [Pg.284]

Uchida N, Okamura S, Kuwano H (1999) Phospholipase D activity in human gastric carcinoma. Anticancer Res 19 671-675... [Pg.114]

Zheng SY, Li DC, Zhang ZD, et al. Adenovirus-mediated FasL gene transfer into human gastric carcinoma. World J Gastroenterol 2005 11(22) 3446-3450. [Pg.308]

Diaz-Meco MT, Municio MM, Frutos S, Sanchez P, Lozano J, Sanz L, Moscat J (1996) The product of par 4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86 777-786 Dietel M, Arps H, Lage H, Niendorf A (1990) Membrane vesicle formation due to acquired mitoxanthrone resistance in human gastric carcinoma cell line EPG85-257. Cancer Res 50 6100-6106... [Pg.68]

UFT was studied in combination with radiation therapy in patients with locally advanced, inoperable gastric carcinoma. Tsukiyama et al. (66) evaluated combined modality therapy (CMT) consisting of UFT and mitomycin-C administered together with radiation therapy, and reported local control in 70% of patients with advanced inoperable gastric cancer. [Pg.35]

Type III tumor Subcardial gastric carcinoma, which infiltrates the esophagogastric junction and distal esophagus from below. [Pg.223]

Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83(10) 2049-2053. [Pg.232]

Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998 82(4) 621-631. [Pg.233]

The role of postoperative chemotherapy for gastric carcinoma is still not clearly defined. Numerous prospective, randomized trials have been conducted in the United States and Europe, producing conflicting results. For example, Hermans et al. (14), in a meta-analysis of 123 trials, 11 of which could be analyzed for crude mortality odds, showed no improvement in survival after adjuvant chemotherapy. However, at the 1998 American Society of Clinical Oncology (ASCO) meeting, Earle et al. (15) presented a reanalysis of the literature. Twelve trials met the criteria for inclusion in this metaanalysis. They found a small survival benefit in the group that received adjuvant chemotherapy. Currently, postoperative adjuvant chemotherapy is not recommended. [Pg.257]

Maeda K, Chung YS, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996 77 858-863. [Pg.346]

Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000 6 519-525. [Pg.405]

In a study investigating the prediction of response to preoperative chemotherapy in gastric carcinoma, Ott et al. [85] included 44 patients with locally advanced gastric cancer. Using the same criterion for differentiating metabolic responders and nonresponders as defined by Weber et al. [82], early response assessment by [ F]-FDG-PET turned out to predict histopathologic response with a sensitivity of 77% and specificity of 86%, respectively. Lordick et al. [222] prospectively... [Pg.165]

K. Ott, U. Fink, K. Becker, A. Stahl, H.J. Dittler, R. Busch, H. Stein, F. Lordick, T. Link, M. Schwaiger, J.R. Siewert, W.A. Weber, Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging Results of a prospective trial, J. Clin. Oncol. 21(24) (2003) 4604 610. [Pg.187]

In various human tumour cell lines (lymphoblastic cell line, CCRF CEM gastric carcinoma cell line, St 23132 hepatoma-derived cell line, HepG2 colon-carcinoma cell line, Caco-2) coumarin [IC50 values ranging from 232 to 522 pg/mL] and its major metabolite 7-hydroxycoumarin [IC50 values ranging from 110 to 436 pg/mL] inhibited... [Pg.207]

Ajani JA, Faust J, Ikeda K et al. Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. J Clin Oncol 2005 23 6957-6965. [Pg.169]

Zhou HB, Chen JJ, Wang WX, Cai JT, Du Q. 2005. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 11 280-284. [Pg.359]

The cytotoxic effect of curcumin on gastric carcinoma cell lines has been established. In a study curcumin and 5-fluorouracil (5-FU) synergistically inhibited the growth of gastric carcinoma cells. In another study, curcumin reversed the MDR of a human gastric carcinoma cell line in correlation with a decrease in P-gp function and a promotion of caspase-3 activation [Anand et al., 2008]. [Pg.365]

Jain, S., Isabel, P., Felipe, M., Gullick, W. J., Linehan, J., and Morris, R. W. 1991. C-erb B-2 protooncogene expression and its relationship to survival in gastric carcinoma an immunohisto-chemical study on archival material. Int. J. Cancer 48 668-671. [Pg.323]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...